Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10609729 | chr1:56334415 | TAGAC/T | 2.01E-7 | 174 | 25.7 | 25.67 | 13.27 | KM Plot |
PCPG | rs1061647 | chr16:89806063 | G/C | 0.000188 | 175 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs10656258 | chr3:194784894 | C/CAA | 0.000144 | 170 | 24.38 | 28.47 | 10.07 | KM Plot |
PCPG | rs1067089 | chr17:3269862 | G/C | 0.00022 | 172 | 18.1 | 25.43 | 26.88 | KM Plot |
PCPG | rs1067091 | chr17:3240297 | G/C | 0.000207 | 172 | 18.1 | 25.87 | 27.2 | KM Plot |
PCPG | rs1067094 | chr17:3285471 | A/T | 0.000196 | 174 | 18.1 | 25.43 | 27.23 | KM Plot |
PCPG | rs1067096 | chr17:3247650 | T/A | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs10671686 | chr7:6637361 | C/CAG | 0.00014 | 172 | 17.62 | 24.7 | 25.4 | KM Plot |
PCPG | rs1068692 | chr17:3270284 | A/G | 0.00022 | 172 | 18.1 | 25.43 | 26.88 | KM Plot |
PCPG | rs10714656 | chr4:78947485 | AT/A | 0 | 176 | 2.93 | 25.87 | 25.28 | KM Plot |
PCPG | rs10716873 | chr8:6725694 | TA/T | 1.27E-6 | 174 | 8.2 | 18.2 | 27.23 | KM Plot |
PCPG | rs10771 | chr16:1749358 | G/A | 1.21E-11 | 176 | 25.53 | 19.3 | 4.52 | KM Plot |
PCPG | rs10774295 | chr12:5117900 | A/C | 2.75E-5 | 178 | 25.6 | 23.77 | 14.4 | KM Plot |
PCPG | rs10774432 | chr12:6565750 | A/G | 0.000285 | 173 | 19.3 | 25.4 | 25.87 | KM Plot |
PCPG | rs10776494 | chr4:78949738 | C/T | 0 | 176 | 2.93 | 25.87 | 25.28 | KM Plot |